← Leaderboards
Theresa W Guilbert
University Of Arizona
$569,739
Attributed
$569,739
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $123.4K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$569,739 · 1
By mechanism
K08$569,739 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Fernando D Martinez$68,375,515
- Tony L Yaksh$23,138,803
- Janko Nikolich-Zugich$55,130,377
- Clara Curiel-Lewandrowski$4,151,872
- Deepta Bhattacharya$12,519,010
Others in their field
Top investigators on “Toll Like Receptor”
- Alan A Aderem · University Of Washington$30,692,449
- Peter Scott Heeger · Case Western Reserve University$28,249,918
- Jenny P.y. Ting · Univ Of North Carolina Chapel Hill$21,923,218
- Douglas T. Golenbock · Boston Medical Center$21,600,792
- Joe G. N. Garcia · University Of Florida$21,368,450
- Bali Pulendran · Stanford University$20,712,326
Research focus
Toll Like ReceptorCytokineRespiratory Syncytial VirusHuman SubjectClinical ResearchInfant Human (0-1 Year)Virus Infection MechanismPreschool Child (1-5)Family GeneticsGenetic PolymorphismGenetic SusceptibilityRespiratory InfectionsImmunogeneticsInflammationRespiratory Disorder EpidemiologyDirect ApplicationBronchiolitisConcanavalin ABaseAntigens, ViralGenesGene Environment InteractionChildhoodFuture
Grant awards (6)
Innate Immunity and RSV Infection in Children$123,381
K08 · FY2007 · HL · contact PI
Innate Immuity and RSV Infection in Children$102,168
K08 · FY2006 · HL · contact PI
Innate Immuity and RSV Infection in Children$11,989
K08 · FY2006 · HL · contact PI
Innate Immuity and RSV Infection in Children$113,423
K08 · FY2005 · HL
Innate Immuity and RSV Infection in Children$114,335
K08 · FY2004 · HL
Innate Immunity and RSV Infection in Children$104,443
K08 · FY2003 · HL